AVX-235

N/A

Report date: 2025/06/11 11:00:33
NME

Base Information

Drug NameAVX-235
Drug Alias NamecPLA2 inhibitor (Avexxin)AVX-003AVX-235
ClassificationSmall molecules
Mechanisms of ActionCytosolic phospholipase A2 inhibitors
TargetsCytosolic phospholipase A2
Therapy Area/IndicationsGlomerulonephritisTriple Negative Breast NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNorway
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCoegin Pharma AB
China Registration ClassN/A

Develop Information

Active CompaniesCoegin Pharma AB
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast Neoplasms
Inactive IndicationsGlomerulonephritisNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A